简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Fractyl Health报告第一季度业绩

2025-05-14 04:26

  • Fractyl Health press release (NASDAQ:GUTS): Q1 Net loss was $23.7 million, compared to $3.3 million for the same period in 2024, largely due to the fluctuation in the non-cash change in fair value of notes and warrants and partially driven by increase in operating expenses of $3.2 million.
  • As of March 31, 2025, Fractyl had approximately $42.1 million in cash and cash equivalents. Based on current operating plans, the Company believes its cash position will fund operations into the fourth quarter of 2025.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。